Cargando…
The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies
In order to improve the safety of COVID-19 vaccines, there is an urgent need to unravel the pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT), a severe complication of recombinant adenoviral vector vaccines used to prevent COVID-19, and likely due to anti-platelet factor 4 (P...
Autores principales: | Vayne, Caroline, Palankar, Raghavendra, Billy, Sandra, Handtke, Stefan, Thiele, Thomas, Cordonnier, Charlotte, Pouplard, Claire, Greinacher, Andreas, Gruel, Yves, Rollin, Jérôme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521230/ https://www.ncbi.nlm.nih.gov/pubmed/35385923 http://dx.doi.org/10.3324/haematol.2021.280251 |
Ejemplares similares
-
The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ
por: Vayne, Caroline, et al.
Publicado: (2021) -
Variable serotonin release assay pattern and specificity of PF4‐specific antibodies in HIT, and clinical relevance
por: Rollin, Jérôme, et al.
Publicado: (2022) -
Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets
por: Wolf, Robert, et al.
Publicado: (2022) -
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022) -
Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)